Circulating plasma lncRNAs as novel markers of EGFR mutation status and monitors of epidermal growth factor receptor‐tyrosine kinase inhibitor therapy

BACKGROUND: Epidermal growth factor receptor (EGFR) gene mutations predict tumor response to EGFR tyrosine kinase inhibitors (EGFR‐TKIs) in non‐small cell lung cancer (NSCLC). However, even patients with EGFR‐sensitive mutations in NSCLC have limited efficacy with EGFR‐TKI. Studies have shown that l...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Thorac Cancer
Main Authors: Lv, Panpan, Yang, Shaoxing, Liu, Wenjing, Qin, Haifeng, Tang, Xiuhua, Wu, Fangfang, Liu, Zeyuan, Gao, Hongjun, Liu, Xiaoqing
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons Australia, Ltd 2019
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6938758/
https://ncbi.nlm.nih.gov/pubmed/31691525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13216
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker